Literature DB >> 9370023

Pattern of self-administered paracetamol and codeine analgesic consumption after mandibular third-molar surgery.

T I Berge1.   

Abstract

Pattern of analgesic consumption after unilateral mandibular third-molar surgery was investigated in an open study in 201 patients. All patients were supplied with six analgesic tablets containing 500 mg paracetamol and 30 mg codeine. Instructions for use were given. A mean consumption of 4.9 tablets over the 1st week and 3.6 tablets the day of operation was found. Eight (4%) patients indicated inadequate or no effect of the medication. The remaining patients were able to control pain, to a level of one-third of maximum pain, by using from one to five tablets. One hundred and thirty-two (68%) patients followed instructions with regard to start of medication. No difference in mean tablet consumption was found between compliant patients and those who delayed the intake of the first analgesic dose by more than 1 h. Predictor analysis showed the most powerful predictors to be preoperative depth of the third molar and moderate or heavy smoking. Thirteen per cent explanatory power of all predictors together was found.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9370023     DOI: 10.3109/00016359709114963

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  3 in total

Review 1.  Tobacco control for anesthesiologists.

Authors:  David O Warner
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

2.  Influences of smoking and caffeine consumption on trigeminal pain processing.

Authors:  Dagny Holle; Anke Heber; Steffen Naegel; Hans-Christoph Diener; Zaza Katsarava; Mark Obermann
Journal:  J Headache Pain       Date:  2014-06-13       Impact factor: 7.277

Review 3.  The Efficacy and Clinical Safety of Various Analgesic Combinations for Post-Operative Pain after Third Molar Surgery: A Systematic Review and Meta-Analysis.

Authors:  Alvin Ho Yeung Au; Siu Wai Choi; Chi Wai Cheung; Yiu Yan Leung
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.